Nasdaq grts.

EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Nov 24, 2023 · Gritstone bio (GRTS) Stock Price, News & Analysis $1.37 -0.01 (-0.72%) (As of 11/14/2023 ET) Compare Today's Range $1.36 $1.49 50-Day Range $1.19 $2.85 52-Week Range $1.14 $4.05 Volume 1.57 million shs Average Volume 1.17 million shs Market Capitalization $130.62 million P/E Ratio N/A Dividend Yield N/A Price Target $7.33 clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was ...EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

According to the issued ratings of 4 analysts in the last year, the consensus rating for Gritstone bio stock is Buy based on the current 4 buy ratings for GRTS. The average twelve-month price prediction for Gritstone bio is $7.33 with a high price target of $8.00 and a low price target of $7.00. Learn more on GRTS's analyst rating history.Gritstone bio, Inc. Common Stock (GRTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Aug 1, 2023 · Financials. GRTS has a market cap of $169mn and a cash balance of $153mn. Research and development expenses were $30.5 million for the three months ended March 31, 2023 while general and ...

GRTS; Advanced Chart. Stock Screener · Earnings Calendar · Sectors · Nasdaq. Search Ticker. |. GRTS U.S.: Nasdaq. Gritstone bio Inc. Watchlist. Alert. NEW. Set ...GRTS Gritstone bio Inc Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine6 ธ.ค. 2564 ... (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, and CEPI ...Oct 25, 2022 · EMERYVILLE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

Nov 25, 2023 · Gritstone Bio Inc (NASDAQ:GRTS) trade information. After registering a 3.79% upside in the last session, Gritstone Bio Inc (GRTS) has traded red over the past five days. The stock hit a weekly high of 1.4100 this Friday, 11/24/23, jumping 3.79% in its intraday price action. The 5-day price performance for the stock is 0.00%, and -28.27% over 30 ...

GRTS. , 30 Long. KozakHlib Updated Dec 7, 2020. Contextual immersion trading strategy idea. Gritstone Oncology, Inc., an immuno-oncology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types. The demand for shares of the company looks higher than the supply.

Oct 30, 2023 · In the last trading session, 1.12 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $1.89 changed hands at -$0.06 or -3.08% during last session, the market valuation stood at $175.92M. GRTS’s last price was a Gritstone bio (NASDAQ:GRTS) shareholders have endured a 70% loss from investing in the stock three years ago (Simply Wall St.) Jun-13-23 07:00AM Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) Jun …Nov 25, 2023 · Gritstone Bio Inc (NASDAQ:GRTS) trade information. After registering a 3.79% upside in the last session, Gritstone Bio Inc (GRTS) has traded red over the past five days. The stock hit a weekly high of 1.4100 this Friday, 11/24/23, jumping 3.79% in its intraday price action. The 5-day price performance for the stock is 0.00%, and -28.27% over 30 ... Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Grifols, S.A. American Depositary Shares (GRFS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Stock analysis for Gritstone bio Inc (GRTS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Web

Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced today that it was awarded a contract by the Biomedical ...20 ม.ค. 2564 ... (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, and ...Gritstone bio, Inc. Common Stock (GRTS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.WebEMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...In the last trading session, 1.12 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $1.89 changed hands at -$0.06 or -3.08% during last session, the market valuation stood at $175.92M. GRTS’s last price was aOct 30, 2023 · In the last trading session, 1.12 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $1.89 changed hands at -$0.06 or -3.08% during last session, the market valuation stood at $175.92M. GRTS’s last price was a

The stock price for Gritstone Bio ( NASDAQ: GRTS) is $ 1.31 last updated Today at November 27, 2023, 10:46 AM PST. Q.Web

Find the latest Insider Activity data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. GRTS technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Gritstone bio, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more.Nov 14, 2023 · Gritstone Bio Inc (NASDAQ:GRTS) trade information. Sporting -3.50% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 11/13/23 when the GRTS stock price touched $1.38 or saw a rise of 25.61%. Gritstone bio Inc (NASDAQ:GRTS) has announced results with its SLATE v1 product ("off-the-shelf" shared neoantigen immunotherapy).; The therapy is in combination with Bristol-Myers Squibb Co's ...The Oct. 25 announcement pushed Gritstone's stock from $2.23 per share that morning to $2.43 at the next day's opening, a 9% increase. Five Gritstone PIPE investors received 6.6 million shares for ...Overview Stock Screener Earnings Calendar Sectors Nasdaq | GRTS U.S.: Nasdaq Gritstone bio Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 14, …WebManagement criteria checks 3/4. Gritstone bio's CEO is Andrew Allen, appointed in Aug 2015, has a tenure of 8.25 years. total yearly compensation is $2.68M, comprised of 23.2% salary and 76.8% bonuses, including company stock and options. directly owns 1.6% of the company’s shares, worth $2.07M. The average tenure of the management team and ...Apr 19, 2021 · The big shareholder groups in Gritstone Oncology, Inc. (NASDAQ:GRTS) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have ... Get the latest GRTS (GRTS) real-time quote, historical performance, charts, and ... Home GRTS • NASDAQ. add. Share. GRTS. $1.88. After Hours: $1.93. ( 2.66%)+ ...

3 วันที่ผ่านมา ... Gritstone bio, Inc. Common Stock (GRTS) · GRTS Option $5.00 May 17, 2024.

EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...

GRTS Historical Data. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...Jul 4, 2023 · So spare a thought for the long term shareholders of Gritstone bio, Inc. (NASDAQ:GRTS); the share price is down a whopping 70% in the last three years. That might cause some serious doubts about ... GRCL. Gracell Biotechnologies Inc. 5.05. -0.25. -4.72%. In this piece, we will take a look at the 12 Best Stocks For Day Trading. If you want to skip our introduction to trading indicators and the ...GRTS Historical Data. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Gritstone Bio Inc (NASDAQ:GRTS) trade information. Sporting -3.50% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 11/13/23 when the GRTS stock price touched $1.38 or saw a rise of 25.61%.EMERYVILLE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...So spare a thought for the long term shareholders of Gritstone bio, Inc. (NASDAQ:GRTS); the share price is down a whopping 70% in the last three years. That might cause some serious doubts about ...Gritstone bio, Inc. (GRTS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.3100 -0.0100 (-0.76%) As of 03:13PM EST. Market open. 1d 5d 1m 6m YTD 1y 5y

Nov 15, 2023 · The average trading volume of GRTS on November 15, 2023 was 2.18M shares. GRTS) stock’s latest price update. Gritstone Bio Inc (NASDAQ: GRTS)’s stock price has gone rise by 8.72 in comparison to its previous close of 1.37, however, the company has experienced a -11.86% decrease in its stock price over the last five trading days. Find the latest dividend history for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.You can practice and explore trading GRTS stock methods without spending real money on the virtual paper trading platform. Webull offers GRTS Ent Holdg (GRTS) historical stock prices, in-depth market analysis, NASDAQ: GRTS real-time stock quote data, in-depth charts, free GRTS options chain data, and a fully built financial calendar to help you ...Instagram:https://instagram. inpixon newswhy is amd stock droppingbest day trading simulator free2009 bicentennial penny EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...About Gritstone Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious ... dynatrace inclandlord insurance los angeles Jul 15, 2021 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. nvidia cramer The big shareholder groups in Gritstone Oncology, Inc. (NASDAQ:GRTS) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have ...The 36-month beta value for GRTS is also noteworthy at 0.44. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for GRTS is $10.40, which is $9.08 above than the current price.Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced today that it was awarded a contract by the Biomedical ...